Project: Ghana Emergency Medicine Collaborative
Document Title: Evaluation and Management of Epistaxis
Author(s): Patrick ...
Attribution Key
for more information see: http://open.umich.edu/wiki/AttributionPolicy
Use + Share + Adapt
Make Your Own A...
Patrick	
  Carter	
  
University	
  of	
  Michigan	
  
Department	
  of	
  Emergency	
  Medicine	
  
July	
  8,	
  2008	
 ...
ObjecKves	
  
ž 	
  Epidemiology	
  
ž 	
  Review	
  of	
  Anatomy	
  
ž 	
  Pathology/EKology	
  
ž 	
  EvaluaKon	
  ...
Hippocrates	
  –	
  4th	
  Century	
  B.C.	
  
Nosebleeds	
  occur	
  in	
  
those	
  who	
  are	
  
beginning	
  to	
  ha...
Epidemiology	
  
ž 	
  	
  60%	
  of	
  populaKon	
  with	
  at	
  least	
  one	
  nosebleed	
  
ž 	
  	
  6-­‐10%	
  wi...
Anatomical	
  ConsideraKons	
  
ž Nasal	
  Cavity	
  
ž FuncKons	
  
ž Respiratory	
  
ž ProtecKve	
  
ž Drainage	
  ...
EKology	
  of	
  Epistaxis	
  
ž 	
  85%	
  of	
  cases	
  are	
  idiopathic	
  
ž 	
  Four	
  Broad	
  Categories:	
  	...
EKology	
  of	
  Epistaxis 	
  	
  
ž 	
  InfecKous	
  EKology	
  
ž 	
  URI	
  
ž 	
  SinusiKs	
  
ž 	
  RhiniKs	
  
...
EKology	
  of	
  Epistaxis	
  
ž 	
  Tumors/Lesions	
  
ž 	
  Nasopharyngeal	
  Neoplasms	
  
ž 	
  Sinus	
  Neoplasms	...
Hereditary	
  Hemorrhagic	
  Telangiectasia	
  
ž 	
  	
  Osler-­‐Weber-­‐Rendu	
  Disease	
  
ž 	
  	
  First	
  descri...
EKology	
  of	
  Epistaxis	
  
ž Disorders	
  of	
  Hemostasis	
  
ž Platelet	
  DisrupKon	
  
ž  Leukemia	
  
ž  Thro...
What	
  about	
  Hypertension?	
  
ž 	
  No	
  clear	
  associaKon	
  between	
  
acute	
  hypertensive	
  episode	
  and...
Clinical	
  EvaluaKon	
  
ž 	
  History	
  
ž LocaKon/Severity	
  
ž Previous	
  Episodes	
  
ž PMH/MedicaKons	
  
ž ...
Anterior	
  Epistaxis	
  Management	
  
ž 	
  Sample	
  Algorithm	
  
ž 	
  First	
  Aid	
  Maneuvers	
  
ž 	
  Direct	...
Digital	
  Pressure	
  (Trofer’s	
  Method)	
  
ž 	
  ApplicaKon	
  of	
  digital	
  pressure	
  over	
  Kiesselbach’s	
 ...
 	
  	
  	
  	
  	
  	
  	
  	
  	
  Merocel	
  Packing	
  
ž 	
  Nasal	
  Tampon	
  inserted	
  
horizontally	
  aoer	
 ...
Rapid	
  Rhino	
  	
  
ž 	
  Balloon	
  Catheter	
  coated	
  
in	
  carbocymethylcellulose	
  
mesh	
  which	
  acts	
  ...
Formal	
  Anterior	
  Packing	
  
ž 	
  Pack	
  the	
  nasal	
  cavity	
  with	
  xeroform	
  ribbon	
  gauze	
  from	
  ...
Posterior	
  Epistaxis	
  
ž 	
  Foley	
  Catheter	
  
ž 	
  Specialized	
  products	
  
ž 	
  Brighton	
  Balloons	
  ...
TradiKonal	
  Posterior	
  Packing	
  
1.  Catheter	
  through	
  affected	
  nostril	
  and	
  through	
  the	
  
nasophar...
AlternaKve	
  Treatments	
  
ž Surgical	
  Therapies	
  
ž 	
  Electrocautery	
  
ž 	
  Septal	
  Surgery	
  
ž 	
  Ar...
ComplicaKons	
  of	
  Packing	
  
ž 	
  Failure	
  to	
  control	
  bleeding	
  
ž 	
  Toxic	
  Shock	
  Syndrome	
  
ž...
Summary	
  
ž 	
  Epistaxis	
  is	
  common	
  complaint	
  affecKng	
  60%	
  of	
  populaKon	
  at	
  
some	
  point	
  ...
QuesKons	
  
25	
  
References	
  
ž Alter,	
  Harrison.	
  Approach	
  to	
  the	
  adult	
  with	
  epistaxis.	
  www.uptodate.com.	
  
Acc...
Upcoming SlideShare
Loading in …5
×

GEMC: Evaluation and Management of Epistaxis: Resident Training

1,797 views

Published on

This is a lecture by Dr. Patrick Carter from the Ghana Emergency Medicine Collaborative. To download the editable version (in PPT), to access additional learning modules, or to learn more about the project, see http://openmi.ch/em-gemc. Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Share Alike-3.0 License: http://creativecommons.org/licenses/by-sa/3.0/.

Published in: Education
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,797
On SlideShare
0
From Embeds
0
Number of Embeds
7
Actions
Shares
0
Downloads
43
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

GEMC: Evaluation and Management of Epistaxis: Resident Training

  1. 1. Project: Ghana Emergency Medicine Collaborative Document Title: Evaluation and Management of Epistaxis Author(s): Patrick Carter (University of Michigan), 2008 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Share Alike-3.0 License: http://creativecommons.org/licenses/by-sa/3.0/ We have reviewed this material in accordance with U.S. Copyright Law and have tried to maximize your ability to use, share, and adapt it. These lectures have been modified in the process of making a publicly shareable version. The citation key on the following slide provides information about how you may share and adapt this material. Copyright holders of content included in this material should contact open.michigan@umich.edu with any questions, corrections, or clarification regarding the use of content. For more information about how to cite these materials visit http://open.umich.edu/privacy-and-terms-use. Any medical information in this material is intended to inform and educate and is not a tool for self-diagnosis or a replacement for medical evaluation, advice, diagnosis or treatment by a healthcare professional. Please speak to your physician if you have questions about your medical condition. Viewer discretion is advised: Some medical content is graphic and may not be suitable for all viewers. 1  
  2. 2. Attribution Key for more information see: http://open.umich.edu/wiki/AttributionPolicy Use + Share + Adapt Make Your Own Assessment Creative Commons – Attribution License Creative Commons – Attribution Share Alike License Creative Commons – Attribution Noncommercial License Creative Commons – Attribution Noncommercial Share Alike License GNU – Free Documentation License Creative Commons – Zero Waiver Public Domain – Ineligible: Works that are ineligible for copyright protection in the U.S. (17 USC § 102(b)) *laws in your jurisdiction may differ Public Domain – Expired: Works that are no longer protected due to an expired copyright term. Public Domain – Government: Works that are produced by the U.S. Government. (17 USC § 105) Public Domain – Self Dedicated: Works that a copyright holder has dedicated to the public domain. Fair Use: Use of works that is determined to be Fair consistent with the U.S. Copyright Act. (17 USC § 107) *laws in your jurisdiction may differ Our determination DOES NOT mean that all uses of this 3rd-party content are Fair Uses and we DO NOT guarantee that your use of the content is Fair. To use this content you should do your own independent analysis to determine whether or not your use will be Fair. { Content the copyright holder, author, or law permits you to use, share and adapt. } { Content Open.Michigan believes can be used, shared, and adapted because it is ineligible for copyright. } { Content Open.Michigan has used under a Fair Use determination. } 2  
  3. 3. Patrick  Carter   University  of  Michigan   Department  of  Emergency  Medicine   July  8,  2008   Dan  Keezer  2002  (Flickr)   3  
  4. 4. ObjecKves   ž   Epidemiology   ž   Review  of  Anatomy   ž   Pathology/EKology   ž   EvaluaKon  of  the  paKent  with  Epistaxis   ž   Management   ž Anterior  Epistaxis   ž Posterior  Epistaxis   ž AlternaKve  Therapies   ž ComplicaKons  of  Packing   4  
  5. 5. Hippocrates  –  4th  Century  B.C.   Nosebleeds  occur  in   those  who  are   beginning  to  have   feelings  of  lust  or   who  are  geXng  the   signs  of  manliness   El  Bibliomata  2010  (Flickr)   5  
  6. 6. Epidemiology   ž     60%  of  populaKon  with  at  least  one  nosebleed   ž     6-­‐10%  will  require  medical  treatment   ž     1.6/10,000  will  require  admission   ž     Bimodal  age  distribuKon   ž   High  Incidence  <  10  y/o   ž  30%  of  all  children  0-­‐5  y/o   ž  56%  of  all  children  6-­‐10  y/o   ž   Second  peak:  45-­‐65  y/o   ž     Bleeding  categories   ž Anterior  (90-­‐95%)   ž Posterior  (5-­‐10%)   Cult  Gigolo  2008  (Flickr)   6  
  7. 7. Anatomical  ConsideraKons   ž Nasal  Cavity   ž FuncKons   ž Respiratory   ž ProtecKve   ž Drainage   ž Olfactory   ž Anterior  Nasal  Cavity  =  Lifle’s  Area   ž Kesselbach’s  Plexus   ž  Anterior/Posterior  Ethmoidal  Arteries   ž  SphenopalanKne  artery   ž  Superior  Labial  Artery   ž  Greater  PalanKne  Artery   ž Posterior  Nasal  Cavity   ž SphenopalanKne  Artery   ž Woodruff’s  Plexus   Gray’s  Anatomy  1918  (Wikimedia  Commons)   7  
  8. 8. EKology  of  Epistaxis   ž   85%  of  cases  are  idiopathic   ž   Four  Broad  Categories:     ž Trauma,  InfecKous,  Tumors/Lesions,  Disorders  of  Hemostasis   ž   TraumaKc  Causes   ž   Digital  Trauma   ž   Facial  Trauma   ž   Mucosal  Drying   ž   Foreign  Body   ž   Septal  PerforaKon   ž   Substance  InhalaKon   ž   Barotrauma   ž   Environmental  Irritants   Aaron  Smith  2007  (Flickr)   8  
  9. 9. EKology  of  Epistaxis     ž   InfecKous  EKology   ž   URI   ž   SinusiKs   ž   RhiniKs   ž   Tuberculosis   ž   Mononucleosis   ž   Scarlet  Fever   ž   RheumaKc  Fever   ž   Syphilis   Sevoo  (Flickr)   9  
  10. 10. EKology  of  Epistaxis   ž   Tumors/Lesions   ž   Nasopharyngeal  Neoplasms   ž   Sinus  Neoplasms   ž   Benign  Nasal  Polyps   ž   Juvenile  Angiofibrinoma   ž   MetastaKc  Lesions   ž   Nasal  Hemangiomas   ž   HHT  (Hereditary  Hemorrhagic  Telangiectasia)   MathieuMD  (WikimediaCommons)   10  
  11. 11. Hereditary  Hemorrhagic  Telangiectasia   ž     Osler-­‐Weber-­‐Rendu  Disease   ž     First  described  in  1864   ž     Mucocutaneous  telangiectasias  +  AV  MalformaKon   ž     U.S.  Incidence  =  1/16,500   ž     Curacao  Criteria   ž     Recurrent  Epistaxis  (90%)   ž     Treatment   ž   Standard  therapies   ž   Surgical  intervenKon   Herbert  L.  Fred,  MD  and  Hendrik  A.  van  Dijk  (Wikimedia  Commons)   11  
  12. 12. EKology  of  Epistaxis   ž Disorders  of  Hemostasis   ž Platelet  DisrupKon   ž  Leukemia   ž  Thrombocytopenia   ž  Von-­‐Willibrand’s  Disease   ž  MedicaKons  (Aspirin,  Plavix,  NSAID’s)     ž CloXng  Cascade  DisrupKon   ž  Hemophilia   ž  Vitamin  K  Deficiency   ž  AnK-­‐coagulant  MedicaKons  (Coumadin,  Heparin,  Lovenox)   ž   AplasKc  Anemia   ž   Polycythemia  Vera   ž   Systemic  Diseases   ž  HepaKc  Disease   ž  Uremia   ž  Alcoholism   NaKonal  Cancer  InsKtute  (WikimediaCommons)   12  
  13. 13. What  about  Hypertension?   ž   No  clear  associaKon  between   acute  hypertensive  episode  and   epistaxis   ž   Chronic  Hypertension  =  Vascular   Damage   ž Increases  risk  of  epistaxis   ž Acute  hypertension  =  Prolonged   Epistaxis   ML5  (WikimediaCommons)   13  
  14. 14. Clinical  EvaluaKon   ž   History   ž LocaKon/Severity   ž Previous  Episodes   ž PMH/MedicaKons   ž Facial  Trauma   ž Recent  InfecKons   ž RecreaKonal  Drug  Use   ž   Physical  Exam   ž Nasal  Speculum   ž SucKon   ž Adequate  Light   ž Posterior  Oropharynx   ž   Laboratory  Studies   ž CBC,  PT/INR,  PTT,  Type  and  Screen   sarindam7  (WikimediaCommons)   14  
  15. 15. Anterior  Epistaxis  Management   ž   Sample  Algorithm   ž   First  Aid  Maneuvers   ž   Direct  Pressure   ž   Nasal  PreparaKon   ž Anesthesia   ž Vasoconstrictors   ž   Cautery   ž Silver  Nitrate  SKcks   ž Electocautery   Source  Undetermined   15  
  16. 16. Digital  Pressure  (Trofer’s  Method)   ž   ApplicaKon  of  digital  pressure  over  Kiesselbach’s  plexus   for  at  least  15-­‐20  minutes   Pinch  here   SuperFantasKc   16  
  17. 17.                    Merocel  Packing   ž   Nasal  Tampon  inserted   horizontally  aoer  lubricaKon   of  pack  with  bacitracin  or  KY-­‐ Jelly  and  then  allowed  to   expand  aoer  saturaKon  with   normal  saline.   17  
  18. 18. Rapid  Rhino     ž   Balloon  Catheter  coated   in  carbocymethylcellulose   mesh  which  acts  as  a   lubricant  and  platelet   aggregator.   ž   The  catheter  is  soaked  in   water  for  30  seconds  and   then  inserted  into  the   nose  along  the  base  of  the   nasopharynx.   ž The  cuff  is  then  inflated   with  air/water  unKl  it   provides  adequate   tamponade.   18  
  19. 19. Formal  Anterior  Packing   ž   Pack  the  nasal  cavity  with  xeroform  ribbon  gauze  from   the  floor  upwards  in  an  accordion  fashion  using  a   bayonet  forceps  leaving  a  four  inch  tail  on  each  end   out  of  nares   19  
  20. 20. Posterior  Epistaxis   ž   Foley  Catheter   ž   Specialized  products   ž   Brighton  Balloons   ž   Simpson  Balloons   ž   Formal  Posterior  Packing   20  
  21. 21. TradiKonal  Posterior  Packing   1.  Catheter  through  affected  nostril  and  through  the   nasopharynx  is  drawn  out  the  mouth  by  ring  forceps.     2.  A  gauze  pack  is  secured  to  the  end  of  the  catheter  with   umbilical  tape  or  suture  material,  and  long  tails  protrude   from  the  mouth.   3.   The  gauze  pack  is  guided  through  the  mouth  and  around   the  soo  palate     4.  The  gauze  pack  in  the  posterior  nasal  cavity  maintaining   tension  on  the  catheter  with  a  padded  clamp  or  firm  gauze   roll  placed  anterior  to  the  nostril.     21  
  22. 22. AlternaKve  Treatments   ž Surgical  Therapies   ž   Electrocautery   ž   Septal  Surgery   ž   Arterial  LigaKon   ž AlternaKve  Treatments   ž   Angiographic  EmbolizaKon   ž   Fibrin  Glue   ž   Laser  Therapy   ž   Hot  Water  IrrigaKon   22  
  23. 23. ComplicaKons  of  Packing   ž   Failure  to  control  bleeding   ž   Toxic  Shock  Syndrome   ž   Blockage  of  Duct  drainage   ž   Nasovagal  Reflex  (Controversial)   ž   ObstrucKve  Sleep  Apnea   ž   Airway  obstrucKon   ž   Removal  can  cause  re-­‐bleeding   ž   Pressure  necrosis   23  
  24. 24. Summary   ž   Epistaxis  is  common  complaint  affecKng  60%  of  populaKon  at   some  point  in  lifeKme   ž Key  to  evaluaKon  is  differenKaKon  between  anterior  and   posterior  bleeding  source   ž Anterior  =  90-­‐95  %  (from  Kiesselbach’s  plexus)   ž Posterior  =  5-­‐10%  (from  sphenopalanKne  artery)   ž Consider  possible  causes  for  epistaxis  with  recurrent  or  difficult   to  control  nosebleeds   ž   Non-­‐invasive  techniques  will  stop  the  majority  of  epistaxis   (Trofer’s  method,  cautery,  vasoconstricKve  compounds)   ž Difficulty  to  control  epistaxis  may  require  nasal  packing   ž Consider  anKbioKcs  while  packing  in  place   ž Posterior  nasal  bleeds  should  all  be  hospitalized   24  
  25. 25. QuesKons   25  
  26. 26. References   ž Alter,  Harrison.  Approach  to  the  adult  with  epistaxis.  www.uptodate.com.   Accessed  6/29/08.   ž Corry,  J.  Kucik  et  al.  Management  of  Epistaxis.  Am  Fam  Physician.  2005  Jan   15;  71  (2):305-­‐311.   ž Leong,  SC  et  al.  No  Frills  Management  of  Epistaxis.  Emerg  Med  J.   2005;22:470-­‐472.   ž Messner,  A.  EvaluaKon  of  epistaxis  in  Children.  www.uptodate.com.   Accessed  6/29/08.   ž Middleton,  P.  Epistaxis.  Emergency  Medicine  Australasia.  2004;  16:   428-­‐440.   ž Pope,  LE  et  al.  Epistaxis:  An  update  on  Current  Management.  Postgraduate   Med  J.  2005;81:309-­‐314.     ž TinKnelli,  J.  Emergency  Medicine:  Nasal  Emergencies.  McGraw-­‐Hill.  2004.   1476-­‐1479.     ž Viehweg  et  al.  Epistaxis:  Diagnosis  and  Treatment.  Journal  of  Oral   Maxillofacial  Surgery  2006;64:511-­‐518.   26  

×